Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant
Open Access
- 1 January 2005
- journal article
- clinical trial
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (13) , 2004-2008
- https://doi.org/10.3748/wjg.v11.i13.2004
Abstract
AIM: This study aims at exploring the distribution of TCM syndromes in CHB patients with HBV pre-core mutation (1896) and the relationship between pre-core mutation and T lymphocytes subgroup, through which to provide objective data on clinical syndrome differentiation of TCM, and further to suggest the therapeutic principle and guide clinical treatment. METHODS: One hundred and forty CHB patients were evenly divided into two study groups, HBV pre-core mutant group and HBV pre-core wild-type group. Besides, 30 healthy blood donors were selected as a healthy control group. HBV-labeled compound, T lymphocytes subgroup, and HBV-DNA pre-core mutant were tested in the study groups. T lymphocytes subgroup were also tested in the control group. All the patients were both diagnosed by syndrome differentiation of TCM and western medicine. RESULTS: The most common syndrome in mutant group was damp-heat combined with blood stasis, and the most common syndrome in the wild-type group was damp-heat stasis in the middle-jiao. There were more cases of medium and severe hepatitis in mutant group than that in wild-type group. The content of CD4+ lymphocytes and CD4+/CD8+ ratio were decreased gradually (healthy control group>wild-type group>mutant group). In the wild-type group, severe and medium CHB patients had considerably lower level of them than mild CHB patients. However, in the mutant group, the opposite result appeared. Meanwhile, the content of HBV-DNA in mutant group was higher than that in wild-type group. CONCLUSION: Damp, heat, toxin and blood stasis were the basic pathogens of CHB, whether pre-core mutant or not. CHB with precore mutant may lead to more severe hepatitis. The decreased content of CD4+ lymphocytes and ratio of CD4+/CD8+ may be taken as one of the indices in confirming the deficiency syndrome of CHB patients with pre-core mutation.Keywords
This publication has 19 references indexed in Scilit:
- Response to Interferon-α in Chronic Hepatitis B With and Without Precore Mutant Strain Detected by Mutation Site–specific AssayJournal of Clinical Gastroenterology, 2004
- Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2aLiver International, 2004
- Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.2003
- Abnormal immunity and gene mutation in patients with severe hepatitis-BWorld Journal of Gastroenterology, 2003
- Vertical transmission of hepatitis B virus despite maternal lamivudine therapyThe Lancet, 2002
- Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patientsCancer, 2001
- [Improved APAAP immunocytochemical staining-trace cytotoxicity test plate method for detection of cell surface antigens].2001
- Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patientArthritis & Rheumatism, 2001
- Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.2000
- Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinomaCancer, 2000